The aircraft manufacturer Boeing, granted the authority by the Federal Aviation Administration in 2009 to self-certify compliance, uses that authority to cut regulatory corners—with tragic results.1 A 10-person advisory panel convened by the Federal Drug Administration in 2002 looks at an alarming rise in prescriptions for a Purdue Pharma drug known as OxyContin, but half [...]
↧